(Q28242203)

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

19 November 2022

author name string

P. C. Turnbull

1

1 reference

Europe PubMed Central

PubMed publication ID

1771966

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771966

full work available at URL

19 November 2022

language of work or name

English

0 references

publication date

August 1991

0 references

https://api.elsevier.com/content/article/PII:0264410X9190237Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

https://api.elsevier.com/content/article/PII:0264410X9190237Z?httpAccept=text/plain

19 November 2022

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

19 November 2022

0 references

9

0 references

issue

8

0 references

page(s)

533-9

0 references

cites work

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig

13

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Field Evaluation of a Human Anthrax Vaccine

19 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Immunization studies with attenuated strains of Bacillus anthracis

19 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Recent advances in the development of an improved, human anthrax vaccine.

19 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Purification of factor I and recognition of a third factor of the anthrax toxin

19 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity

19 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells

19 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Production and purification of anthrax toxin

19 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Purification of anthrax-toxin components by high-performance anion-exchange, gel-filtration and hydrophobic-interaction chromatography

19 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis

19 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Role of epidemiology in vaccine policy

19 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain

19 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.

19 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin.

19 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.

19 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

Anthrax vaccine development: a continuing story

19 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90237-Z

19 November 2022

Identifiers